The Next Edition
  • Home
  • About Us
  • News
  • Featured
  • Investigations
  • Foreign
  • Special Reports
  • Entertainment
  • Interviews
  • Advert Rate
No Result
View All Result
The Next Edition
No Result
View All Result
  • Home
  • About Us
  • News
  • Featured
  • Investigations
  • Foreign
  • Special Reports
  • Entertainment
  • Interviews
  • Advert Rate
Home Top News

UK To Pilot Blood Test That May Detect 50 Types Of Cancer

Next Edition by Next Edition
November 29, 2020
in Top News
9.6m people to die of cancer in 2018 –WHO
0
SHARES
1
VIEWS
Share on FacebookShare on TwitterShare on Whatsapp

The UK’s National Health Service (NHS) is to pilot a simple blood test that may detect more than 50 types of cancer and, it is hoped, could help thousands of people by allowing the disease to be treated more successfully at an earlier stage.

The Galleri blood test, developed by Californian healthcare company Grail, will be piloted with 165,000 patients in what the NHS described as a “world-first deal” in a news release Friday.

You might also like

FG Offers N50m Grant To Outstanding Varsity Students

Truck Crushes Police Inspector To Death In Ogun

Lagos Re-opens Oko-Oba Abbatoir

Grail, whose work is focused on detecting cancer early, is backed by investors including tech billionaire Bill Gates and Amazon founder Jeff Bezos.

NHS England hopes the blood test will be particularly useful in identifying types of cancer that are currently difficult to diagnose and treat early.

“Early detection — particularly for hard-to-treat conditions like ovarian and pancreatic cancer — has the potential to save many lives,” said NHS chief executive Simon Stevens.

More than 1,000 people are newly diagnosed with cancer every day in the UK, he added.

The pilot program, due to start in mid-2021, will involve 165,000 people, including 140,000 aged from 50 to 79 who have no symptoms but will have annual blood tests over three years.

The remaining 25,000 participants will be people with possible cancer symptoms who will be offered the blood test to speed up their diagnosis after they are referred to hospital in the normal way, the news release said.

Results are expected by 2023, after which it is hoped one million people could receive the test by 2025, expanding this to the wider population thereafter, NHS England said.

In England, around half of cancers are currently diagnosed at stage one or two but the NHS aims to increase that to three quarters by 2028, the news release said.

READ ALSO: Gunmen kill Police, Kidnap Chinese Expatriate In Ekiti

Grail said in a press release that according to modeling data, “adding Galleri to existing standard of care has the potential to decrease the number of cancers diagnosed at late stage by nearly half, which could reduce the total number of cancer deaths in the UK by approximately one-fifth.”

Five-year relative survival for cancer in the UK is below the European average, according to charity Cancer Research UK.

Lawrence Young, professor of Molecular Oncology at the University of Warwick, said the Galleri test was one of a number of novel blood tests being developed to detect cancer at a very early stage when it is more easily treated.

“There are a number of trials evaluating this approach and a publication from the Circulating Cell-free Genome Atlas (CCGA) consortium examining the Galleri test in 6,689 participants has generated very encouraging results in more than 50 different cancers at different stages of development,” he told the Science Media Centre.

However, not all cancer experts agree that the NHS should be piloting the Galleri blood test.

Paul Pharoah, professor of Cancer Epidemiology at the University of Cambridge, told the Science Media Centre he had doubts about the scientific basis for the pilot based on the limited published research available.

“The Galleri blood test is a test that might be able to detect cancer in the blood in individuals with early cancer, though the evidence that it does this effectively is weak,” he said. “The NHS should not be investing in such a test before it has been adequately evaluated in well-conducted, large-scale clinical trials.”

CNN

 

Tags: Breast cancercancerCANCER TYPESCANCEROUS DISEASESEnglandHEART CANCERMedical TreatmentNHSSkin CancersurgeryUK's National Health Service (NHS)United Kingdom
Next Edition

Next Edition

Recommended For You

COVID-19: FG Mulls Alternatives on WAEC, Schools Re-opening

FG Offers N50m Grant To Outstanding Varsity Students

  The federal Government has offered a N50 million venture capital grant to outstanding students in Nigerian universities. It was gathered that the grant was for students in...

FCT Police Take Custody Of Suspect Accused Of Taking Woman To Hotel For Ritual

Truck Crushes Police Inspector To Death In Ogun

  A police inspector, Afolabi Adeola, was reportedly killed after he was hit by a truck at a checkpoint along the Abeokuta–Sagamu Motorway in Ogun State. Our correspondent...

Lagos Shuts Oko-Oba Abattoir Over Unsanitary Practices

Lagos Re-opens Oko-Oba Abbatoir

  The Lagos State Government has directed the immediate re-opening of the Oko-Oba Abbatoir in Agege following the fulfillment of sanitation and hygienic prescriptions by the operators. The...

Gunmen Invade Monarch’s Palace In Benue, Kill Son, Abduct Daughter

Gunmen Abduct, Kill Anambra Chief After N15m Ransom

  Panic has gripped the Nimo community in the Njikoka Local Government Area of Anambra State following the murder of a prominent traditional titleholder and community leader popularly...

Next Post
Man City 5-0 Burnley: Riyad Mahrez Nets Hat-trick In Familiar Scoreline

Man City 5-0 Burnley: Riyad Mahrez Nets Hat-trick In Familiar Scoreline




Related News

Killer policeman: Investigation continues –CP

Killer policeman: Investigation continues –CP

WHO Fears ‘Silent’ Virus Epidemic Unless Africa Priorities Testing

WHO Fears ‘Silent’ Virus Epidemic Unless Africa Priorities Testing

Favourable HIV/AIDS status: A’Ibom commercial sex workers anticipate boom in business

Favourable HIV/AIDS status: A’Ibom commercial sex workers anticipate boom in business




The Next Edition

Office Address

3B, Agboola Aina street, Off Toyin Street,
Ikeja, Lagos.

Quick Contact Details

Phone:
08033018430
Whatsapp:
08051679910

Email:
[email protected]
[email protected]

Categories

  • Aviation
  • Beauty
  • Breaking News
  • Business
  • Columnists
  • Editorial
  • Entertainment
  • Fashion
  • Featured
  • Football
  • Foreign
  • Headline News
  • Home & Garden
  • Interviews
  • Investigations
  • North Central
  • North East
  • North West
  • Opinion
  • Parenting
  • Politics
  • Relationships
  • South East
  • South West
  • South-South
  • Special Reports
  • Sports
  • Top News
  • Vox Pops

© Next Edition Business Development Limited

  • About Us
  • Advert Rate
  • Contact Us
  • Privacy Policy
  • Terms of Use
No Result
View All Result
  • Home
  • About Us
  • News
  • Featured
  • Investigations
  • Foreign
  • Special Reports
  • Entertainment
  • Interviews
  • Advert Rate

© Next Edition Business Development Limited